| Dr Brady Cade Blackham, DO | |
|
95 East Center Street, Gunnison, UT 84634 | |
| (435) 528-7227 | |
| (435) 528-2175 |
| Full Name | Dr Brady Cade Blackham |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 95 East Center Street, Gunnison, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679701197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MR-1062 (Idaho) | Secondary |
| 207Q00000X | Family Medicine | 8334270-1204 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gunnison Valley Hospital | Gunnison, UT | Hospital |
| Sevier Valley Hospital | Richfield, UT | Hospital |
| Mission At Community Living Rehabilitation Center | Centerfield, UT | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Utah Clinic Pc | 7517868508 | 391 |
| Gunnison Valley Hospital | 3678487659 | 18 |
News Archive
A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons found that more than one-third of elite, Division I college athletes may have low levels of vitamin D, which is critical in helping the body to absorb calcium needed to maintain bone mass, and to minimize musculoskeletal pain and injury risk.
Anpath Group, Inc., and its wholly-owned subsidiary, EnviroSystems, Inc., today reported financial results for its fiscal 2010 third quarter which ended December 31, 2009.
Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.
Walgreens, the nation's largest drugstore chain and a leading destination for health and wellness services, today announced the re-launch of Walgreens.com (www.walgreens.com), offering users a variety of new healthy living and product resources, along with expanded yet simplified shopping tools and services.
Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.
› Verified 9 days ago
| Entity Name | Central Utah Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093764805 PECOS PAC ID: 7517868508 Enrollment ID: O20040113000805 |
News Archive
A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons found that more than one-third of elite, Division I college athletes may have low levels of vitamin D, which is critical in helping the body to absorb calcium needed to maintain bone mass, and to minimize musculoskeletal pain and injury risk.
Anpath Group, Inc., and its wholly-owned subsidiary, EnviroSystems, Inc., today reported financial results for its fiscal 2010 third quarter which ended December 31, 2009.
Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.
Walgreens, the nation's largest drugstore chain and a leading destination for health and wellness services, today announced the re-launch of Walgreens.com (www.walgreens.com), offering users a variety of new healthy living and product resources, along with expanded yet simplified shopping tools and services.
Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.
› Verified 9 days ago
| Entity Name | Gunnison Valley Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1952463036 PECOS PAC ID: 3678487659 Enrollment ID: O20091103000521 |
News Archive
A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons found that more than one-third of elite, Division I college athletes may have low levels of vitamin D, which is critical in helping the body to absorb calcium needed to maintain bone mass, and to minimize musculoskeletal pain and injury risk.
Anpath Group, Inc., and its wholly-owned subsidiary, EnviroSystems, Inc., today reported financial results for its fiscal 2010 third quarter which ended December 31, 2009.
Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.
Walgreens, the nation's largest drugstore chain and a leading destination for health and wellness services, today announced the re-launch of Walgreens.com (www.walgreens.com), offering users a variety of new healthy living and product resources, along with expanded yet simplified shopping tools and services.
Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brady Cade Blackham, DO 1055 N 500 W, Attn: Credentialing, Provo, UT 84604-3321 Ph: (801) 354-8225 | Dr Brady Cade Blackham, DO 95 East Center Street, Gunnison, UT 84634 Ph: (435) 528-7227 |
News Archive
A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons found that more than one-third of elite, Division I college athletes may have low levels of vitamin D, which is critical in helping the body to absorb calcium needed to maintain bone mass, and to minimize musculoskeletal pain and injury risk.
Anpath Group, Inc., and its wholly-owned subsidiary, EnviroSystems, Inc., today reported financial results for its fiscal 2010 third quarter which ended December 31, 2009.
Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.
Walgreens, the nation's largest drugstore chain and a leading destination for health and wellness services, today announced the re-launch of Walgreens.com (www.walgreens.com), offering users a variety of new healthy living and product resources, along with expanded yet simplified shopping tools and services.
Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.
› Verified 9 days ago
Cary John Judy, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 95 E Center, Gunnison, UT 84634 Phone: 435-528-7227 Fax: 435-528-2175 | |
Gerald J Willden, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 E 100 N, Gunnison, UT 84634 Phone: 435-528-2130 Fax: 435-528-7796 | |
Christine Jackson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 65 East 100 North, Gunnison, UT 84634 Phone: 435-528-2130 Fax: 435-528-2197 | |
Kayla Olson, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 65 East 100 North, Gunnison, UT 84634 Phone: 435-528-2222 | |
Dr. Scott Joseph Walker, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 E. 100 N., Gunnison, UT 84634 Phone: 435-528-2130 | |
Adam Michael Jensen, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 E 100 N, Gunnison, UT 84634 Phone: 435-528-2130 Fax: 435-528-2186 |